Poate AI genera ipoteze științifice plauzibile din vastă literatură biomedicală în câteva secunde ?

Noile sisteme AI pot citi mii de lucrări de cercetare și pot identifica conexiuni noi între studii. Aceste modele folosesc arhitecturi de transformator instruite pe texte biomedicale pentru a propune direcții de cercetare. Companiile farmaceutice le testează pentru a accelera procesele de descoperire a medicamentelor. Ipotezele necesită încă validare experimentală riguroasă înainte de a fi acceptate.

Background

Current systems can ingest millions of abstracts, rapidly surface statistically associated molecular or disease patterns, and even suggest mechanistic links that humans had missed—an approach sometimes called “robot scientist” or literature-based discovery. Pharmaceutical companies are testing them to accelerate drug discovery pipelines. However, the resulting hypotheses still require expert curation to distinguish plausible mechanistic narratives from statistical artifacts and to ensure biological feasibility. In controlled biomedical challenges, AI has produced testable drug–target or disease–pathway hypotheses that were later validated in lab experiments, showing promise but not yet matching the full rigor of hypothesis generation by seasoned investigators. Work continues on making these systems more explainable, reproducible, and aligned with experimental constraints so they can truly operate at “seconds” speed while maintaining scientific trustworthiness.

New AI systems use transformer architectures trained on biomedical texts to propose research directions. Current systems can already ingest millions of abstracts, rapidly surface statistically associated molecular or disease patterns, and even suggest mechanistic links that humans had missed—an approach sometimes called “robot scientist” or literature-based discovery. Pharmaceutical companies are testing them to accelerate drug discovery pipelines. These models use transformer architectures trained on biomedical texts to propose research directions.